An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

doi:10.1084/jem.172.3.947

This Article

	Full Text (PDF, 839K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Jaraquemada, D.
	Articles by Long, E. O.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Jaraquemada, D.
	Articles by Long, E. O.


Social Bookmarking

	What's this?

ARTICLES

An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

D Jaraquemada, M Marti and EO Long
Molecular Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

The recognition of virus-infected cells by class I MHC-restricted cytotoxic T cells requires endogenous processing of antigen for presentation. It is still unclear whether endogenous processing of antigen can be utilized by class II MHC molecules for presentation. To test this possibility, a human B cell line expressing HLA-A2 and HLA- DR1 was infected with a recombinant vaccinia virus expressing the Influenza A virus M1 matrix protein (VAC-M1) and was assayed for lysis by different M1-specific cytolytic T cell lines, restricted by either HLA-A2 or by HLA-DR1. Class II-restricted lysis of VAC-M1-infected cells did occur. This lysis required de novo M1 synthesis and was not due to exogenous antigen. Several properties of the endogenous processing pathway for class II-restricted presentation were different from those of the pathway utilized by class I molecules. First, class II-mediated recognition of VAC-M1 infected cells was less efficient, requiring higher doses of virus and longer infection times, than the class I-mediated recognition. Second, chloroquine completely blocked presentation of endogenous M1 to class II-restricted T cells but had no effect on the class I-restricted presentation. Third, the class II- restricted presentation of M1 was only mildly affected by Brefeldin A, a drug that prevents transport from the endoplasmic reticulum to the Golgi, whereas the class I-restricted presentation of M1 was completely abrogated by this drug. These data demonstrate the existence of an endogenous processing pathway for the presentation of cytosolic antigen by class II molecules and show that this pathway is distinct from the one used for presentation by class I molecules.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Robila, V., Ostankovitch, M., Altrich-VanLith, M. L., Theos, A. C., Drover, S., Marks, M. S., Restifo, N., Engelhard, V. H. (2008). MHC Class II Presentation of gp100 Epitopes in Melanoma Cells Requires the Function of Conventional Endosomes and Is Influenced by Melanosomes. J. Immunol. 181: 7843-7852 [Abstract] [Full Text]
Su, Y., Carey, G., Maric, M., Scott, D. W. (2008). B Cells Induce Tolerance by Presenting Endogenous Peptide-IgG on MHC Class II Molecules via an IFN-{gamma}-Inducible Lysosomal Thiol Reductase-Dependent Pathway. J. Immunol. 181: 1153-1160 [Abstract] [Full Text]
Demirel, O., Waibler, Z., Kalinke, U., Grunebach, F., Appel, S., Brossart, P., Hasilik, A., Tampe, R., Abele, R. (2007). Identification of a Lysosomal Peptide Transport System Induced during Dendritic Cell Development. J. Biol. Chem. 282: 37836-37843 [Abstract] [Full Text]
Mitra-Kaushik, S., Cruz, J., Stern, L. J., Ennis, F. A., Terajima, M. (2007). Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses. J. Immunol. 179: 1303-1312 [Abstract] [Full Text]
Veron, P., Allo, V., Riviere, C., Bernard, J., Douar, A.-M., Masurier, C. (2007). Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2. J. Virol. 81: 5385-5394 [Abstract] [Full Text]
Taylor, G. S., Long, H. M., Haigh, T. A., Larsen, M., Brooks, J., Rickinson, A. B. (2006). A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells. J. Immunol. 177: 3746-3756 [Abstract] [Full Text]
Hegde, N. R., Dunn, C., Lewinsohn, D. M., Jarvis, M. A., Nelson, J. A., Johnson, D. C. (2005). Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. JEM 202: 1109-1119 [Abstract] [Full Text]
Dissanayake, S. K., Tuera, N., Ostrand-Rosenberg, S. (2005). Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome. J. Immunol. 174: 1811-1819 [Abstract] [Full Text]
Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., Munz, C. (2005). Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy. Science 307: 593-596 [Abstract] [Full Text]
Sugahara, D., Tsuji-Kawahara, S., Miyazawa, M. (2004). Identification of a Protective CD4+ T-Cell Epitope in p15gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity. J. Virol. 78: 6322-6334 [Abstract] [Full Text]
Fonteneau, J. F., Kavanagh, D. G., Lirvall, M., Sanders, C., Cover, T. L., Bhardwaj, N., Larsson, M. (2003). Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102: 4448-4455 [Abstract] [Full Text]
Nikiforow, S., Bottomly, K., Miller, G., Munz, C. (2003). Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol. 77: 12088-12104 [Abstract] [Full Text]
Lich, J. D., Jayne, J. A., Zhou, D., Elliott, J. F., Blum, J. S. (2003). Editing of an Immunodominant Epitope of Glutamate Decarboxylase by HLA-DM. J. Immunol. 171: 853-859 [Abstract] [Full Text]
Vaz-Santiago, J., Lule, J., Rohrlich, P., Jacquier, C., Gibert, N., Le Roy, E., Betbeder, D., Davignon, J.-L., Davrinche, C. (2001). Ex Vivo Stimulation and Expansion of both CD4+ and CD8+ T Cells from Peripheral Blood Mononuclear Cells of Human Cytomegalovirus-Seropositive Blood Donors by Using a Soluble Recombinant Chimeric Protein, IE1-pp65. J. Virol. 75: 7840-7847 [Abstract] [Full Text]
Mukherjee, P., Dani, A., Bhatia, S., Singh, N., Rudensky, A. Y., George, A., Bal, V., Mayor, S., Rath, S. (2001). Efficient Presentation of Both Cytosolic and Endogenous Transmembrane Protein Antigens on MHC Class II Is Dependent on Cytoplasmic Proteolysis. J. Immunol. 167: 2632-2641 [Abstract] [Full Text]
Yasukawa, M., Ohminami, H., Kojima, K., Hato, T., Hasegawa, A., Takahashi, T., Hirai, H., Fujita, S. (2001). HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4+ T lymphocytes. Blood 98: 1498-1505 [Abstract] [Full Text]
Linnemann, T., Jung, G., Walden, P. (2000). Detection and Quantification of CD4+ T Cells with Specificity for a New Major Histocompatibility Complex Class II-Restricted Influenza A Virus Matrix Protein Epitope in Peripheral Blood of Influenza Patients. J. Virol. 74: 8740-8743 [Abstract] [Full Text]
Lich, J. D., Elliott, J. F., Blum, J. S. (2000). Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins. JEM 191: 1513-1524 [Abstract] [Full Text]
Bansal, P., Mukherjee, P., Basu, S. K., George, A., Bal, V., Rath, S. (1999). MHC Class I-Restricted Presentation of Maleylated Protein Binding to Scavenger Receptors. J. Immunol. 162: 4430-4437 [Abstract] [Full Text]
Catalfamo, M., Serradell, L., Roura-Mir, C., Kolkowski, E., Sospedra, M., Vives-Pi, M., Vargas-Nieto, F., Pujol-Borrell, R., Jaraquemada, D. (1999). HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules. Int Immunol 11: 269-277 [Abstract] [Full Text]
Yasukawa, M., Ohminami, H., Kaneko, S., Yakushijin, Y., Nishimura, Y., Inokuchi, K., Miyakuni, T., Nakao, S., Kishi, K., Kubonishi, I., Dan, K., Fujita, S. (1998). CD4+ Cytotoxic T-Cell Clones Specific for bcr-abl b3a2 Fusion Peptide Augment Colony Formation by Chronic Myelogenous Leukemia Cells in a b3a2-Specific and HLA-DR-Restricted Manner. Blood 92: 3355-3361 [Abstract] [Full Text]
Armstrong, T. D., Clements, V. K., Martin, B. K., Ting, J. P.-Y., Ostrand-Rosenberg, S. (1997). Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of�tumor-specific�immunity. Proc. Natl. Acad. Sci. USA 94: 6886-6891 [Abstract] [Full Text]
Gueguen, M., Long, E.�O. (1996). Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the�antigen. Proc. Natl. Acad. Sci. USA 93: 14692-14697 [Abstract] [Full Text]
Moss, B (1991). Vaccinia virus: a tool for research and vaccine development. Science 252: 1662-1667 [Abstract]